secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001193125-25-328951
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight CFO Shelley Thunen to transition; consulting agreement through Dec 2026
-------------------------------------------------------------------------------

- CFO Shelley Thunen to depart by Jan 31, 2026 or upon appointment of successor; will serve as consultant thereafter.
- Consulting agreement provides $15,000 monthly retainers for Jan-Mar 2026, plus $500/hour for services.
- Thunen remains eligible for fiscal 2025 annual cash bonus based on corporate performance.
- Outstanding stock options continue vesting during consulting term ending Dec 31, 2026.
- No successor named; Ron Kurtz cites nearly decade of service; company has 1,100+ LDDs and 250k+ procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312525328951/0001193125-25-328951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312525328951/d19913d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-328951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer